J. Gangoiti

发表

A model‐driven quantitative metabolomics analysis of aerobic and anaerobic metabolism in E. coli K‐12 MG1655 that is biochemically and thermodynamically consistent

Adam M. Feist, Zachary A. King, B. Palsson, 2014, Biotechnology and bioengineering.

Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.

T. Ideker, L. Natarajan, R. Naviaux, 2013, Journal of the American Society of Nephrology : JASN.

Validation of a dual LC–HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics

J. Gangoiti, B. Barshop, I. Gertsman, 2013, Metabolomics.

Metabolomics identifies perturbations in human disorders of propionate metabolism.

W. R. Wikoff, G. Siuzdak, J. Gangoiti, 2007, Clinical chemistry.

A pH and solvent optimized reverse-phase ion-paring-LC–MS/MS method that leverages multiple scan-types for targeted absolute quantification of intracellular metabolites

Adam M. Feist, B. Palsson, A. Feist, 2015, Metabolomics.

Dairy Fat Intake, Plasma C15: 0 and Plasma Iso-C17: 0 are Inversely Associated with Liver Fat in Children.

Alexandra N. Schlein, Christian M. Metallo, C. Sirlin, 2020, Journal of pediatric gastroenterology and nutrition.

Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes

L. Natarajan, K. Sharma, J. Gangoiti, 2020, PloS one.

The mPEG-PCL Copolymer for Selective Fermentation of Staphylococcus lugdunensis Against Candida parapsilosis in the Human Microbiome

Chun-Ming Huang, J. Gangoiti, B. Barshop, 2016, Journal of microbial & biochemical technology.

Changes in Expression of DNA-Methyltransferase and Cannabinoid Receptor mRNAs in Blood Lymphocytes After Acute Cannabis Smoking

A. Lajtha, H. Sershen, D. Janowsky, 2022, Frontiers in Psychiatry.

Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery

P. Rioux, J. Gangoiti, B. Barshop, 2014, Fundamental & clinical pharmacology.

renal excretion of uric acid Multiple organic anion transporters contribute to net

W. R. Wikoff, V. Vallon, T. Rieg, 2016 .

Metabolomic biomarkers from patients with Barth syndrome treated with elamipretide: insights from the TAZPOWER study

D. Brown, P. Oates, J. Gangoiti, 2020, medRxiv.

PDE9 Inhibition Activates PPARα to Stimulate Mitochondrial Fat Metabolism and Reduce Cardiometabolic Syndrome

Dorothy D. Sears, D. Kass, B. O’Rourke, 2021, bioRxiv.

Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice.

Dorothy D. Sears, B. O’Rourke, D. Sears, 2021, The Journal of clinical investigation.

Analysis of coenzyme Q in human blood and tissues.

J. Gangoiti, B. Barshop, 2007, Mitochondrion.

Long-term treatment of cystinosis in children with twice-daily cysteamine.

J. Gangoiti, B. Barshop, R. Dohil, 2010, The Journal of pediatrics.

Inhibition of HDAC8 and HDAC9 by microbial short-chain fatty acids breaks immune tolerance of the epidermis to TLR ligands

Chun-Ming Huang, J. Gangoiti, R. Gallo, 2016, Science Immunology.

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.

J. Kurhanewicz, P. Sneed, P. Munster, 2018, Blood advances.

Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone.

J. Keiser, D. Siegel, C. Caffrey, 2020, The Journal of antimicrobial chemotherapy.

The role of DMQ9 in the long-lived mutant clk-1

P. Morgan, M. Sedensky, J. Gangoiti, 2011, Mechanisms of Ageing and Development.

Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

J. Duffield, J. Gangoiti, B. Barshop, 2014, Journal of the American Society of Nephrology : JASN.

Diagnosis and Monitoring of Cystinosis Using Immunomagnetically Purified Granulocytes.

J. Gangoiti, B. Barshop, I. Gertsman, 2016, Clinical chemistry.

Positive newborn screen in the biochemically normal infant of a mother with treated holocarboxylase synthetase deficiency

W. Nyhan, J. Gangoiti, B. Barshop, 2009, Journal of Inherited Metabolic Disease.

Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice*

V. Vallon, T. Rieg, J. Gangoiti, 2006, Journal of Biological Chemistry.

Twice-daily cysteamine bitartrate therapy for children with cystinosis.

Bruce A Barshop, J. Gangoiti, B. Barshop, 2010, The Journal of pediatrics.

Understanding intestinal cysteamine bitartrate absorption.

R. Deutsch, J. Gangoiti, B. Barshop, 2006, The Journal of pediatrics.

Perturbations of tyrosine metabolism promote the indolepyruvate pathway via tryptophan in host and microbiome.

W. Nyhan, J. Gangoiti, B. Barshop, 2015, Molecular genetics and metabolism.

Multiple organic anion transporters contribute to net renal excretion of uric acid.

W. R. Wikoff, G. Siuzdak, V. Vallon, 2008, Physiological genomics.

The effect of different ubiquinones on lifespan in Caenorhabditis elegans

P. Morgan, M. Sedensky, J. Gangoiti, 2009, Mechanisms of Ageing and Development.

Cardiac tissue citric acid cycle intermediates in exercised very long‐chain acyl‐CoA dehydrogenase‐deficient mice fed triheptanoin or medium‐chain triglyceride

M. Gillingham, C. Harding, J. Gangoiti, 2020, Journal of inherited metabolic disease.

A pH and solvent optimized reverse-phase ion-paring-LC–MS/MS method that leverages multiple scan-types for targeted absolute quantification of intracellular metabolites

Adam M. Feist, A. Feist, D. McCloskey, 2015, Metabolomics.

Tumor Metabolism and Neurocognition in CNS Lymphoma.

J. Kurhanewicz, D. Vigneron, T. Luks, 2021, Neuro-oncology.

Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.

W. Nyhan, J. Gangoiti, B. Barshop, 2015, JIMD reports.

Organic anion transporter 3 contributes to the regulation of blood pressure.

W. R. Wikoff, G. Siuzdak, V. Vallon, 2008, Journal of the American Society of Nephrology : JASN.

Validation of a dual LC–HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics

J. Gangoiti, B. Barshop, I. Gertsman, 2014, Metabolomics.

Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion.

R. Deutsch, J. Gangoiti, B. Barshop, 2007, British journal of clinical pharmacology.

The Effect of Food on Cysteamine Bitartrate Absorption in Healthy Participants

P. Rioux, J. Gangoiti, R. Dohil, 2012, Clinical pharmacology in drug development.

Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.

J. Gangoiti, B. Barshop, R. Dohil, 2010, British journal of clinical pharmacology.